Saving changes...

Done

Error

Newest Oncology Agents: PD-1 Inhibitors - Clinical Information and Patient Management

Newest Oncology Agents: PD-1 Inhibitors - Clinical Information and Patient Management

Newest Oncology Agents: PD-1 Inhibitors - Clinical Information and Patient Management

Megan Brafford, PharmD, BCOP And David Kwasny, PharmD, BCOP
Megan Brafford, PharmD, BCOP And David Kwasny, PharmD, BCOP
on behalf of ProCE Inc.

FREE
FREE
FREE

FREE
FREE
FREE

null FREE
FREE
FREE
null FREE
FREE
FREE
Normal Price: FREE FREE

Review:

Launch date: 08 Mar 2017
Expiry Date:

Last updated: 13 Mar 2017

Reference: 170955

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

This is a featured CE activity on the Center for Specialty Pharmacy Education (CSPE) website. CSPE is the educational hub of the National Association of Specialty Pharmacy (NASP). Most CSPE activities include the pathophysiology and clinical therapeutics of various disease states in which specialty pharmacy products and services are provided. CSPE also covers legal, regulatory and operational topics relevant to specialty pharmacy practice.Oncology agents continue to dominate new product developments in specialty pharmacy practice. PD-1s are the newest agents and are expected to have significant impact on patient care. The clinical data for these products is relatively new to the literature, and many went through an accelerated approval process with the FDA; therefore, it is imperative that providers stay on top of the latest information regarding dosing, administration, adverse effects, monitoring, and patient outcomes.

Objectives

Objectives
Learning Objectives:The target audience for this activity is pharmacists. Upon completion of this activity, participants will be able to:Discuss the current clinical data and utilization results of PD-1s.Discuss dosing, safety, and efficacy data available for PD-1s.Outline supportive care requirements that may assist patients in achieving a positive oncology outcome.
Megan Brafford, PharmD, BCOP And David Kwasny, PharmD, BCOP

Author Information Play Video Bio

Megan Brafford, PharmD, BCOP And David Kwasny, PharmD, BCOP
on behalf of ProCE Inc.

Megan Brafford, PharmD, BCOP Clinical Oncology Pharmacy Specialist Baptist Health LexingtonDavid Kwasny, PharmD, BCOP Director, Clinical Oncology Services Onco360 Oncology Pharmacy

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 1.00 Hours -
    Exam Pass Rate: 75
    -
    Reference: 0221-9999-16-102-H01-P

Faculty and Disclosures

Additional Contributors

null

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error